|
|
Article: Sorin Group Innovates in the Hemodynamic Management of Heart Failure With the European Introduction of its New Generation Cardiac Resynchronization Therapy Products.
- Article from:
- PR Newswire
- Article date:
- October 4, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
VENICE, Italy, October 4 /PRNewswire-FirstCall/ -- Sorin Group Cardiac Rhythm Management (CRM) Business Unit, an innovative leader in the development of cardiac rhythm management therapies, announced today at the Venice Arrhythmias 2005 Congress, the European launch of OVATIO(TM) CRT and NewLiving(TM) CHF, respectively its new cardiac resynchronization therapy defibrillator (CRT-D) and pacemaker (CRT-P) for the treatment of heart failure patients.
Heart failure is a major cardiac condition affecting 10 million Europeans(1) and more than 22 million people worldwide(2) and is expected to almost triple in 2020. According to the European Society of Cardiology (ESC) ...